What's Going On With Jaguar Health Stock?

Jaguar Health, Inc. JAGX shares are blasting higher and reached high of 66 cents during premarket trading Thursday. 

What To Know:

Jaguar Health is exhibiting at the Veterinary Cancer Society Annual Conference from Oct. 12 through Oct 14. to promote Canalevia-CA1, the company's FDA-conditionally approved drug product for the treatment of chemotherapy-induced diarrhea in dogs.

Jaguar Health is a commercial-stage pharmaceutical company focused on developing plant-based, non-opioid and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic diarrhea. 

Shares of JAGX are moving on extremely heavy trading volume Thursday. According to data from Benzinga Pro, more than 90 million shares have already been traded in the session, far exceeding the stock's 100-day average volume of just over 833 thousand shares.

Jaguar Health is watched by retail investors as a frequently volatile penny-stock and is currently one of the top trending tickers on Yahoo! Finance. 

Related News: What's Going On With Lucid Group Stock?

JAGX Price Action: According to Benzinga Pro, Jaguar Health shares are up 93% at 47 cents at the time of publication.

Image: Ian Lindsay from Pixabay